Duration of Heart Failure Is an Important Predictor of Outcomes after Mechanical Circulatory Support

Circulation: Heart Failure

Volumn 8, Issue 5, 2015, Pages 953-959

  Loyaga Rendon, Renzo Y ^a   Acharya, Deepak ^a   Pamboukian, Salpy V ^a   Tallaj, Jose A ^a   Cantor, Ryan ^b   Starling, Randall C ^d   Naftel, David C ^c   Kirklin, James K ^c  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b University of Texas Austin Regional Campus   (United States)

^c University of Alabama at Birmingham   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Heart failure; heart transplantation; humans; risk factors; ventricular assist device

Indexed keywords

ACUTE HEART FAILURE; ADULT; ADVERSE OUTCOME; ARTICLE; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; BLACK PERSON; CAUCASIAN; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DISEASE DURATION; FEMALE; GROUPS BY AGE; HEART FAILURE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT HISTORY OF SURGERY; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RIGHT VENTRICULAR ASSIST DEVICE; RISK FACTOR; TOTAL ARTIFICIAL HEART; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; EPIDEMIOLOGY; FOLLOW UP; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGISTER; RISK ASSESSMENT; SURVIVAL RATE; TIME; TRENDS; UNITED STATES;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 84953344855     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002321     Document Type: Article

References (25)

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147-e239. doi: 10.1016/j.jacc.2013.05.019.
2. Cleland JG, Carubelli V, Castiello T, Yassin A, Pellicori P, Antony R. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev. 2012;17:133-149. doi: 10.1007/s10741-012-9306-2.
3. Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest. 2012;42:153-163. doi: 10.1111/j.1365-2362.2011.02573.x.
4. Sila CA. Cognitive impairment in chronic heart failure. Cleve Clin J Med. 2007;74 Suppl 1:S132-S137.
5. Fülster S, Tacke M, Sandek A, Ebner N, Tschöpe C, Doehner W, Anker SD, von Haehling S. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34:512-519. doi: 10.1093/eurheartj/ehs381.
6. Verbrugge FH, Dupont M, Vercammen J, Jacobs L, Verhaert D, Vandervoort P, Tang WH, Mullens W. Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response. Heart. 2013;99:314-319. doi: 10.1136/heartjnl-2012-302807.
7. McGiffin DC, Naftel DC, Kirklin JK, Morrow WR, Towbin J, Shaddy R, Alejos J, Rossi A. Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis. Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 1997;16:713-722.
8. Blackstone EH ND, Turner MR, Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615-624.
9. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Miller MA, Timothy Baldwin J, Young JB. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014;33:555-564. doi: 10.1016/j.healun.2014.04.010.
10. Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Schwarz P, Faber J. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine. 2013;43:626-634. doi: 10.1007/s12020-012-9836-3.
11. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Givertz MM, Young JB. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. J Heart Lung Transplant. 2013;32:1205-1213. doi: 10.1016/j.healun.2013.09.001.
12. Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka Y, Schulze PC. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant. 2012;31:601-610. doi: 10.1016/j.healun.2012.02.027.
13. Kato TS, Kitada S, Yang J, Wu C, Takayama H, Naka Y, Farr M, Mancini DM, Schulze PC. Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. Am J Cardiol. 2013;112:1484-1488. doi: 10.1016/j.amjcard.2013.06.023.
14. Dunlay SM, Park SJ, Joyce LD, Daly RC, Stulak JM, McNallan SM, Roger VL, Kushwaha SS. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014;33:359-365. doi: 10.1016/j.healun.2013.12.014.
15. Teeter WA, Thibodeau JT, Rao K, Brickner ME, Toto KH, Nelson LL, Mishkin JD, Ayers CR, Miller JG, Mammen PP, Patel PC, Markham DW, Drazner MH. The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation. Am Heart J. 2012;164:358-364. doi: 10.1016/j.ahj.2012.06.009.
16. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Pinã IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N; Acute Heart Failure Syndromes International Working Group. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009;157:957-970. doi: 10.1016/j. ahj.2009.04.010.
17. Gregoric ID. Mechanical circulatory support in acute heart failure. Tex Heart Inst J. 2012;39:854-855.
18. Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, Acharya D, Cantor R, Starling RC, Naftel D, Kirklin J. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for mechanically assisted circulatory support. Circ Heart Fail. 2014;7:300-309. doi: 10.1161/CIRCHEARTFAILURE.113.000721.
19. McNamara DM, Starling RC, Cooper LT, Boehmer JP, Mather PJ, Janosko KM, Gorcsan J, 3rd, Kip KE, Dec GW; IMAC Investigators. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol. 2011;58:1112-1118. doi: 10.1016/j.jacc.2011.05.033.
20. Goldstein DJ, Maybaum S, MacGillivray TE, Moore SA, Bogaev R, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail. 2012;18:392-395. doi: 10.1016/j.cardfail.2012.01.020.
21. McCarthy RE, 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690-695. doi: 10.1056/NEJM200003093421003.
22. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535-541. doi: 10.1016/j.healun.2009.02.015.
23. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141-156. doi: 10.1016/j. healun.2012.12.004.
24. Heidecker B, Lamirault G, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Hall J, Kittleson MM, Baughman KL, Hare JM. The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. Eur Heart J. 2010;31:1188-1196. doi: 10.1093/eurheartj/ehp549.
25. Boehmer JP, Starling RC, Cooper LT, Torre-Amione G, Wittstein I, Dec GW, Markham DW, Zucker MJ, Gorcsan J, 3rd, McTiernan C, Kip K, McNamara DM; IMAC Investigators. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. J Card Fail. 2012;18:755-761. doi: 10.1016/j.cardfail.2012.08.001.